On 4-5 October, the EPAD communication team held a meeting at the VUmc Alzheimercentrum in Amsterdam to review the project’s communication strategy. On the first day, the agenda covered what the members of the EPAD WP6 communication team have achieved so far. The communications activities from 2015-2018 were reviewed to analyse their strengths, weaknesses and…
World Alzheimer’s Month is the international campaign to raise awareness and challenge the stigma that surrounds dementia. September 2018 is World Alzheimer’s Month (WAM), including World Alzheimer’s Day (WAD) on 21 September. The 7th global WAM utilises the theme of “Every 3 seconds” to emphasise the huge global impact of dementia worldwide. As every year…
The European Prevention of Alzheimer’s Dementia (EPAD) project launched in 2017 its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop academic research capacity and output in Alzheimer’s disease (AD) across Europe for maximum global impact. The EPAD Academy is first focusing on activities to support early career researchers. For…
The members of the EPAD initiative are glad to announce that its Longitudinal Cohort Study has recruited its 1,000th participant at the University of Oxford (UK) this 21st September on World Alzheimer’s Day. EPAD is one of the world leading dementia prevention studies, led from the University of Edinburgh. It is a Europe-wide collaboration aiming…
EPAD recruited its first French research participant in September 2016 via the Gerontopole of Toulouse University Hospital (CHUT, Toulouse, France). It was the first site to open in France and the fourth in Europe and has currently recruited over 130 participants. The main mission of this institute is to develop research and prevention through multidisciplinary…
Abstract: Many healthy volunteers choose to take part in Alzheimer’s disease (AD) prevention studies because they want to know whether they will develop dementia—and what they can do to reduce their risk—and are therefore interested in learning the results of AD biomarker tests. Proponents of AD biomarker disclosure often refer to the personal utility of…
On 29 August, EPAD’s Scottish team were lucky enough to visit the stunning University of Aberdeen campus for the inaugural EPAD Scotland conference. Held in the historic heart of the University, almost 80 delegates including participants, site staff and the wider Scottish EPAD team were treated to an uplifting and informative day of talks, as…
We are pleased that for the first time during our project, we exhibited the EPAD study at the Alzheimer’s Association International Conference (AAIC) held on 22-26 July. With its neat white walls and signature green colours, the EPAD booth at the start of the exhibition area at this year’s record size AAIC in Chicago stood…
What is your current role in EPAD? I have recently joined the executive committee of EPAD. The executive committee is suggested to follow up on the project to see if everything is performed as planned and help coordinate between different ongoing activities. As well, it is a group that can react to new developments e.g.…
What is your current role in EPAD? I am a member of Work Package 7 focusing on business and sustainability for the EPAD project. We are conducting analysis pertaining to markets, stakeholders, incentive, IP and financial strategy. Ultimately, we are collaborating with the entire consortium to create a feasible business plan for the EPAD machine.…
